Tyrosine Kinase Inhibitors: all 10,469 studies that test it

Page 45 of 105. Open to participants first (1,907), then studies with results posted, then the rest; newest registration first within each.

• Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsCompletedNCT00561795Phase 2Results posted
• Dasatinib in Combination With Revlimid (and Dexamethasone)CompletedNCT00560391Phase 1Results posted
• Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple MyelomaTerminatedNCT00560352Phase 1Results posted
• Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By SurgeryCompletedNCT00559507Phase 2Results posted
• A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00558636Phase 3Results posted
• Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseCompletedNCT00558272Phase 2Results posted
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast CancerCompletedNCT00558103Phase 2Results posted
• Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell CarcinomaTerminatedNCT00557830Phase 2Results posted
• Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00557193Phase 3Results posted
• A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00556712Phase 3Results posted
• A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00556322Phase 3Results posted
• Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaCompletedNCT00556049Phase 2Results posted
• Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric CancerCompletedNCT00555672Phase 1Results posted
• Imatinib Mesylate (Gleevec) in the Treatment of Systemic SclerosisCompletedNCT00555581Phase 2Results posted
• Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In SituCompletedNCT00555152Not applicableResults posted
• Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00553800Phase 2Results posted
• Study Of Sunitinib With S-1 And Cisplatin For Gastric CancerCompletedNCT00553696Phase 1Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00553462Phase 2Results posted
• Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) StudyCompletedNCT00553358Phase 3Results posted
• Trial Of PF-00299804 In Patients With Advanced Refractory Lung CancerCompletedNCT00553254Phase 2Results posted
• Dasatinib in Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00550615Phase 1/2Results posted
• Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00550537Phase 2Results posted
• A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid ArthritisCompletedNCT00550446Phase 2Results posted
• A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerCompletedNCT00550173Phase 2Results posted
• A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid ArthritisCompletedNCT00550043Phase 2Results posted
• Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedNCT00549848Phase 3Results posted
• Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung CancerTerminatedNCT00549328Phase 2Results posted
• Lapatinib and Trastuzumab With or Without Endocrine TherapyCompletedNCT00548184Phase 2Results posted
• PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And ErlotinibCompletedNCT00548093Phase 2Results posted
• Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00547105Phase 2Results posted
• Phase II Dasatinib Study in Advanced Breast CancerCompletedNCT00546104Phase 2Results posted
• Dasatinib in Treating Patients With Stage IV Pancreatic CancerTerminatedNCT00544908Phase 2Results posted
• Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma MultiformeCompletedNCT00544817Phase 2Results posted
• Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast CancerCompletedNCT00544167Not applicableResults posted
• Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)CompletedNCT00542971Phase 1/2Results posted
• Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by SurgeryTerminatedNCT00539617Phase 2Results posted
• Dasatinib in Polycythemia VeraTerminatedNCT00538980Phase 2Results posted
• Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerCompletedNCT00537095Phase 2Results posted
• Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRICompletedNCT00537056Not applicableResults posted
• Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma PatientsCompletedNCT00536575Phase 1/2Results posted
• Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00536107Phase 4Results posted
• Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract CarcinomasTerminatedNCT00532441Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.CompletedNCT00531960Phase 2Results posted
• Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) SubjectsCompletedNCT00529763Phase 2Results posted
• AZD0530 in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00528645Phase 2Results posted
• Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00527124Phase 2Results posted
• Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian CancerTerminatedNCT00526799Phase 1/2Results posted
• Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And LapatinibCompletedNCT00526669Phase 2Results posted
• Sunitinib in Treating Patients With Locally Advanced Bladder CancerCompletedNCT00526656Phase 2Results posted
• Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or GliosarcomaCompletedNCT00525525Phase 2Results posted
• Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast CancerTerminatedNCT00525161Phase 2Results posted
• LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating MutationsCompletedNCT00525148Phase 2Results posted
• Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryTerminatedNCT00524316Phase 2Results posted
• Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00524121Phase 2Results posted
• Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second RemissionTerminatedNCT00522301Phase 2Results posted
• Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerCompletedNCT00519896Phase 2Results posted
• Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)TerminatedNCT00519090Phase 3Results posted
• Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and NeckCompletedNCT00519077Phase 2Results posted
• A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.CompletedNCT00518011Phase 2Results posted
• BIBW 2992 (Afatinib) in Head & Neck CancerCompletedNCT00514943Phase 2Results posted
• Sunitinib in Treating Patients With Relapsed Multiple MyelomaCompletedNCT00514137Phase 2Results posted
• Vandetanib to Treat Children and Adolescents With Medullary Thyroid CancerCompletedNCT00514046Phase 1/2Results posted
• Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerCompletedNCT00513695Phase 2Results posted
• Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00513435Phase 2Results posted
• AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00513071Phase 2Results posted
• A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic SclerosisCompletedNCT00512902Phase 1/2Results posted
• Gleevec Study for Patients With Ovarian CancerCompletedNCT00510653Phase 2Results posted
• Sorafenib in Myelodysplastic SyndromeTerminatedNCT00510289Phase 2Results posted
• Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia MyelofibrosisCompletedNCT00509899Phase 1/2Results posted
• Pazopanib in Treating Patients With Recurrent or Metastatic Breast CancerCompletedNCT00509587Phase 2Results posted
• Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received ChemotherapyCompletedNCT00509093Phase 2Results posted
• Dasatinib in Treating Patients With Previously Treated Malignant MesotheliomaCompletedNCT00509041Phase 2Results posted
• Iressa Study in Patients With Salivary Gland CancerCompletedNCT00509002Phase 2Results posted
• Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From ChinaTerminatedNCT00508274Phase 3Results posted
• Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)CompletedNCT00508001Phase 2Results posted
• Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00507767Phase 2Results posted
• Imatinib in Systemic SclerosisCompletedNCT00506831Phase 1/2Results posted
• Gleevec/Taxol for Patients With Uterine Papillary Serous CarcinomaTerminatedNCT00506779Phase 1/2Results posted
• Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00504153Phase 2Results posted
• Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.TerminatedNCT00503971Phase 1/2Results posted
• Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast CancerTerminatedNCT00503841Not applicableResults posted
• A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell CarcinomaCompletedNCT00502307Phase 2Results posted
• A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal CancerCompletedNCT00500292Phase 2Results posted
• Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate CancerCompletedNCT00500110Phase 2Results posted
• Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML PatientsTerminatedNCT00499889Phase 2Results posted
• Sunitinib in Treating Patients With Recurrent Malignant GliomasCompletedNCT00499473Phase 2Results posted
• Sorafenib in Treating Patients With Metastatic or Unresectable Kidney CancerTerminatedNCT00496756Phase 2Results posted
• Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast CancerTerminatedNCT00496366Phase 2Results posted
• Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)TerminatedNCT00495625Phase 2Results posted
• CEP-701 for PH-negative MyelofibrosisCompletedNCT00494585Phase 2Results posted
• E3 Breast Cancer Taxotere CombinationCompletedNCT00494481Phase 2Results posted
• Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)CompletedNCT00494299Phase 3Results posted
• A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOXCompletedNCT00494221Phase 1/2Results posted
• 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) TherapyCompletedNCT00493636Phase 2Results posted
• Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By SurgeryTerminatedNCT00493025Phase 2Results posted
• A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT00492752Phase 3Results posted
• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DCompletedNCT00490139Phase 3Results posted
• Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent ChemotherapyTerminatedNCT00490061Phase 2Results posted
• Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric CancerCompletedNCT00486954Phase 3Results posted
• Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00486642Phase 2Results posted

← Tyrosine Kinase Inhibitors overview